Identification of High Risk People for Colorectal Cancer and Evaluation of a Specific Surveillance System (ISIRECC)
Identification of High Risk People for Colorectal Cancer in Indre-et-Loire (France) and Evaluation of a Specific Surveillance System : a Randomized Trial Assessing the Efficacy of a Letter Encouraging People to Perform Colonoscopy Screening
Colorectal cancer is one the most frequent cancer in developed countries. In France, it rank third with 43000 new cases in 2015. French Health Authority recommended colonoscopy screening for people with a high risk for colorectal cancer. But this compliance with colonoscopy is low (20-40%), it is therefore necessary to develop new strategies to improve compliance.
The purpose of this project is to to offer and evaluate the feasibility and the effectiveness of a specific surveillance system for high risk people for colorectal cancer
The project will be divided into 2 phases:
Objectives of the first phase:
- Identify high risk people for colorectal cancer in the department of Indre-et-Loire,
- Fill in as completely as possible their colonoscopic history in the past 5 years,
- Estimate the proportion of high risk people for colorectal cancer in the target population for colorectal cancer screening in Indre-et-Loire (Men and women aged from 50 to 74 years).
Objective of the second phase:
Compare the performed colonoscopy rate of high risk people for colorectal cancer without notion of colonoscopy in the past 58 months following or not (control group) the sending of a letter reminding the importance of compliance with colonoscopy.
研究概览
研究类型
注册 (实际的)
阶段
- 不适用
联系人和位置
学习地点
-
-
Indre-et-Loire
-
Tours、Indre-et-Loire、法国、37000
- UH Tours
-
-
参与标准
资格标准
适合学习的年龄
接受健康志愿者
有资格学习的性别
描述
Inclusion Criteria:
- residing in Indre et Loire (France)
- with increased risk for colorectal cancer
- who did not perform a colonoscopy in the past 58 months
Exclusion Criteria:
- none
学习计划
研究是如何设计的？
设计细节
- 主要用途：放映
- 分配：随机化
- 介入模型：并行分配
- 屏蔽：无（打开标签）
武器和干预
参与者组/臂 |
干预/治疗 |
|---|---|
|
实验性的：Reminder letter
A letter is sent for remind the importance of compliance with colonoscopy AND to encourage people to to consult their general practitioner or gastroenterologist (if they haven't done their follow-up in time).
|
The letter will consist in several parts:
|
|
无干预：Control
No intervention (what is done currently)
|
研究衡量的是什么？
主要结果指标
结果测量 |
大体时间 |
|---|---|
|
Calculate the rate of high risk people for colorectal cancer identified in the target population for colorectal cancer screening in Indre-et-Loire (Men and women aged from 50 to 74 years)
大体时间：one year
|
one year
|
|
Comparison of the performed colonoscopy rate within 12 months following randomization / send letter in the 2 arms
大体时间：12 months after sending the letter (/randomization)
|
12 months after sending the letter (/randomization)
|
合作者和调查者
调查人员
- 首席研究员：Somany SENGCHANH, Dr、Centre de Coordination des Dépistages des Cancers CHRU de Tours
- 首席研究员：Ken HAGUENOER, Dr、Centre de Coordination des Dépistages des Cancers
- 首席研究员：Julie Boyard、Centre de Coordination des Dépistages des Cancers
- 学习椅：Thierry Lecomte, Pr、CHRU de Tours, Service Hépato- gastroentérologie
研究记录日期
研究主要日期
学习开始 (实际的)
初级完成 (实际的)
研究完成 (实际的)
研究注册日期
首次提交
首先提交符合 QC 标准的
首次发布 (估计)
研究记录更新
最后更新发布 (实际的)
上次提交的符合 QC 标准的更新
最后验证
更多信息
此信息直接从 clinicaltrials.gov 网站检索，没有任何更改。如果您有任何更改、删除或更新研究详细信息的请求，请联系 register@clinicaltrials.gov. clinicaltrials.gov 上实施更改，我们的网站上也会自动更新.
Reminder letter的临床试验
-
Dana-Farber Cancer Institute邀请报名